Quick Answer
Silence Therapeutics plc reported Gross Profit of $344.0 thousand for the year ending 2025.
- Silence Therapeutics plc showed a decrease of -98.9% in Gross Profit from 2024 to 2025.
- This data is from Silence Therapeutics plc's annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: $12.90 million | Q2 2024: -$2.58 million | Q3 2024: -$2.14 million | Q1 2025: $88.0 thousand | Q2 2025: $139.0 thousand | Q3 2025: $95.0 thousand.
- Over the full 7 years of available data (2019 to 2025), Silence Therapeutics plc's Gross Profit has grown by 41.0%.
- Historical annual values: Fiscal year 2025: $344.0 thousand | Fiscal year 2024: $31.45 million | Fiscal year 2023: $18.78 million | Fiscal year 2022: $8.19 million | Fiscal year 2021: $4.96 million | Fiscal year 2020: $1.72 million | Fiscal year 2019: $244.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: